| Molecular properties prediction and synthesis of novel 1, 3, 4-oxadiazole analogues as potent antimicrobial and antitubercular agents MJ Ahsan, JG Samy, H Khalilullah, MS Nomani, P Saraswat, R Gaur, ... Bioorganic & medicinal chemistry letters 21 (24), 7246-7250, 2011 | 202 | 2011 |
| 1, 3, 4-Oxadiazole: A biologically active scaffold H Khalilullah, M J Ahsan, M Hedaitullah, S Khan, B Ahmed Mini reviews in medicinal chemistry 12 (8), 789-801, 2012 | 160 | 2012 |
| An improved synthesis of Biginelli-type compounds via phase-transfer catalysis B Ahmed, Habibullah, RA Khan, M Keshari Tetrahedron Letters 50 (24), 2889-2892, 2009 | 109 | 2009 |
| Synthesis, characterisation, and in vitro anticancer activity of curcumin analogues bearing pyrazole/pyrimidine ring targeting EGFR tyrosine kinase MJ Ahsan, H Khalilullah, S Yasmin, SS Jadav, J Govindasamy BioMed research international 2013, 2013 | 68 | 2013 |
| Discovery of novel antitubercular 1, 5-dimethyl-2-phenyl-4-([5-(arylamino)-1, 3, 4-oxadiazol-2-yl] methylamino)-1, 2-dihydro-3H-pyrazol-3-one analogues MJ Ahsan, JG Samy, CB Jain, KR Dutt, H Khalilullah, MS Nomani Bioorganic & medicinal chemistry letters 22 (2), 969-972, 2012 | 66 | 2012 |
| Synthesis, characterization and antimicrobial activity of benzodioxane ring containing 1, 3, 4-oxadiazole derivatives H Khalilullah, S Khan, MS Nomani, B Ahmed Arabian Journal of Chemistry 9, S1029-S1035, 2016 | 61 | 2016 |
| Synthesis and antihepatotoxic activity of 5-(2, 3-dihydro-1, 4-benzodioxane-6-yl)-3-substituted-phenyl-4, 5-dihydro-1H-pyrazole derivatives H Khalilullah, S Khan, MJ Ahsan, B Ahmed Bioorganic & medicinal chemistry letters 21 (24), 7251-7254, 2011 | 58 | 2011 |
| Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System MH Akhter, I Ahmad, MY Alshahrani, AI Al-Harbi, H Khalilullah, O Afzal, ... Gels 8 (2), 82, 2022 | 54 | 2022 |
| Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids AK Singh, A Kumar, H Singh, P Sonawane, H Paliwal, S Thareja, ... Pharmaceuticals 15 (9), 1071, 2022 | 50 | 2022 |
| Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective A Kumar, AK Singh, H Singh, V Vijayan, D Kumar, J Naik, S Thareja, ... Pharmaceuticals 16 (2), 299, 2023 | 49 | 2023 |
| Primary prevention with statins in cardiovascular diseases: A Saudi Arabian perspective M Danish, J Kausar, H Khalilullah Journal of Saudi Heart Association 27 (3), 179-191, 2015 | 48 | 2015 |
| Synthesis and antimycobacterial evaluation of 3a, 4-dihydro-3H-indeno [1, 2-c] pyrazole-2-carboxamide analogues MJ Ahsan, JG Samy, H Khalilullah, MA Bakht, MZ Hassan European journal of medicinal chemistry 46 (11), 5694-5697, 2011 | 40 | 2011 |
| Synthesis of some new 3, 4-dihydro-2H-1, 3-benzoxazines under microwave irradiation in solvent-free conditions and their biological activity M Akhter, Habibullah, SM Hasan, MM Alam, N Akhter, ... Medicinal Chemistry Research, 1-7, 2011 | 37 | 2011 |
| An in-silico analysis of ivermectin interaction with potential SARS-CoV-2 targets and host nuclear importin α F Azam, IM Taban, EEM Eid, M Iqbal, O Alam, S Khan, D Mahmood, ... Journal of Biomolecular Structure and Dynamics 40 (6), 2851-2864, 2022 | 36 | 2022 |
| POMA analyses as new efficient bioinformatics’ platform to predict and optimise bioactivity of synthesized 3a, 4-dihydro-3H-indeno [1, 2-c] pyrazole-2-carboxamide … MJ Ahsan, J Govindasamy, H Khalilullah, G Mohan, JP Stables, ... Bioorganic & medicinal chemistry letters 22 (23), 7029-7035, 2012 | 34 | 2012 |
| Synthesis and anticonvulsant activity of 3a, 4-dihydro-3H-indeno [1, 2-c] pyrazole-2-carboxamide/carbothioamide analogues MJ Ahsan, H Khalilullah, JP Stables, J Govindasamy Journal of enzyme inhibition and medicinal chemistry 28 (3), 644-650, 2013 | 33 | 2013 |
| Simple, efficient, and improved synthesis of Biginelli-type compounds of curcumin as anticancer agents R Sharma, SS Jadav, S Yasmin, S Bhatia, H Khalilullah, MJ Ahsan Medicinal Chemistry Research 24, 636-644, 2015 | 32 | 2015 |
| Impact of Protein Corona on the Biological Identity of Nanomedicine: Understanding the Fate of Nanomaterials in the Biological Milieu MH Akhter, H Khalilullah, M Gupta, MA Alfaleh, NA Alhakamy, Y Riadi, ... Biomedicines 9 (10), 1496, 2021 | 31 | 2021 |
| Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials M Jawed Ahsan, M Yousuf Ansari, S Yasmin, S Singh Jadav, P Kumar, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2015 | 28 | 2015 |
| Molecular and Therapeutic: Actions of Thymoquinone H Younus, Sawhney Springer, 2018 | 27 | 2018 |
Dr. Mohamed Jawed AhsanFaculty of Pharmacy, JITEmail yang diverifikasi di kku.edu.sa
